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Summary
In classical descriptions of leukocyte chemokine sig-
naling, Src family kinases are thought to function in a
positive fashion by coupling receptor associated G
subunits to downstream mitogen activated protein
(MAP) kinase activation. However, neutrophils derived
from hck−/−fgr−/− mice and dendritic cells (DCs) from
fgr−/− animals manifested significantly higher intracel-
lular signaling (Ca2+ flux, MAP kinase activation, ac-
tin polymerization) and functional responses (chemo-
taxis in vitro and migration in vivo) to a number of
different chemokines. These kinases may mediate
their effect through the inhibitory receptor PIR-B
since neutrophils and DCs from pir-b−/− mice were
also hyperresponsive to chemokine stimulation. In
wild-type (wt) cells dephosphorylation of PIR-B was
associated with maximal chemokine signaling, whereas
in hck−/−fgr−/− cells PIR-B was unphosphorylated. These
data support a model in which the Src family kinases
Hck and Fgr function as negative regulators of my-
eloid cell chemokine signaling by maintaining the
tonic phosphorylation of PIR-B.
Introduction
Chemokines bind to seven transmembrane-spanning
receptors that utilize heterotrimeric G proteins to trans-
duce intracellular signals. In murine neutrophils, the
primary chemokine receptors are CXCR2 (which recog-
nizes CXCL1 chemokines such as macrophage inflam-
matory protein 2 [MIP-2]) and CCR1 (which recognizes
CCL3 chemokines such as MIP-1α) (Thorpe, 2003). Re-
cruitment of DCs from tissue inflammatory sites to re-
gional lymph nodes is regulated primarily by the chem-
okine receptor CCR7 (which recognizes CCL19 and
CCL21). CCR7 expression is upregulated on maturing
DCs during their migration to regional lymph nodes
(Randolph, 2001). After ligand binding to the chemokine
receptor, the heterotrimeric GTPase is activated, and
the subunits of the enzyme dissociate into the GTP
bound Gαi and Gβγ units, which in turn couple to down-
stream signaling pathways, including activation of pho-*Correspondence: clowell@cgl.ucsf.edu
3 Present address: Threshold Pharmaceuticals, 951 Gateway Blvd.,
South San Francisco, California 94080.spholipases and phophoinositol 3# kinases (PI-3Kα and
PI-3Kγ) (Thelen, 2001). Tyrosine kinase pathways are in-
itiated by the GTP bound Gαi subunits, which are be-
lieved to lead activation of the MAP kinase cascade.
The tyrosine kinases involved in chemokine signaling
are the Src family kinases Pyk2 and Jak family kinases
(Luttrell et al., 1999; Okigaki et al., 2003; Soriano et al.,
2003).
The Src family tyrosine kinases have been implicated
in a number of G protein-coupled receptor (GPCR) sig-
naling pathways in both leukocytes and nonhematopoi-
etic cells. Stimulation of many GPCRs directly in-
creases the enzymatic activity of Src family kinases
(Luttrell et al., 1996; Ptasznik et al., 1995). As isolated
proteins, both Gαi and Gαs subunits bind to and stimu-
late the kinase activity of c-Src and Hck (Ma et al.,
2000). In chicken DT-40 lymphoma cells, Lyn is required
for coupling of Gq-coupled m1 muscarinic acetylcho-
line receptors to downstream MAP kinase activation
(Wan et al., 1997). Both Lyn and Lck are required for
activation of MAP kinases and chemotaxis in myeloid
leukemia cells and T-lymphocytes, respectively, after
stimulation with CXCL12 (SDF-1α) (Inngjerdingen et al.,
2002; Ptasznik et al., 2002). In myeloid leukocytes, the
Src family kinases have been implicated in formyl-pep-
tide Met-Leu-Phe (fMLP) signaling as treatment of neu-
trophils with Src family kinase inhibitors or use of cells
from hck−/−fgr−/−lyn−/− mutant mice blocks degranula-
tion responses to this agonist (Mocsai et al., 1999,
2000). In myeloid cell lines, activation of Hck and Fgr
after CXCL8 stimulation may occur via formation of a
complex with β-arrestin-1 (Barlic et al., 2000). Together,
these reports would suggest that the overall dominant
role for Src family kinases, and specifically for Src fam-
ily members in myeloid leukocytes, is a positive func-
tion in which the kinases propagate downstream sig-
naling pathways after chemokine stimulation.
Studies using mice deficient in the major Src family
kinases present in myeloid leukocytes have demon-
strated that the primary positive signaling role for these
enzymes is in the integrin pathway (Lowell, 2004; Low-
ell and Berton, 1999). Deficiency of Hck and Fgr renders
neutrophils and macrophages nonresponsive to adhe-
sion-mediated activation after crosslinking of β1, β2, or
β3 integrins. However, Src family kinases can also func-
tion as negative regulators. This is particularly true for
Lyn, which serves as both a positive and negative regu-
lator of B cell antigen receptor signaling and cytokine
signaling (DeFranco et al., 1998; Harder et al., 2001).
The inhibitory function of Lyn is mediated by its ability
to phosphorylate immunoreceptor tyrosine-based inhi-
bition motifs (ITIMs) on several transmembrane recep-
tors (FcγRIIB and CD22), which in turn recruit phospha-
tases such as SHIP and SHP-1 that downmodulate
signaling. A potential negative regulatory role for Fgr
in FcγR phagocytosis in macrophages has also been
demonstrated (Gresham et al., 2000). There have been
no investigations of chemokine signaling pathways in
leukocytes derived from these mice.
Myeloid cells express a number of receptors that
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236serve an inhibitory function. In murine cells, the most t
cintensively studied are the paired immunoglobulin-like
wreceptor (PIR-B), signal regulatory phosphatase bind-
sing protein-1 (SIRP-1α), and the inhibitory FcR, FcγRIIB.
iEach of these receptors contains cytoplasmic ITIM do-
wmains that recruit SHP-1 (in the case of PIR-B and
fSIRP-1α) or SHIP (in the case of FcγRIIB). The inhibitory
FcγRIIB receptor functions to downregulate neutrophil
Eand macrophage responses to immune complexes as
wwell as to attenuate B cell production of immunoglobu-
alins. The functions of PIR-B and SIRP-1α are less
tclear—each has been implicated in negative regulation
oof leukocyte adhesion (Pereira and Lowell, 2003; Per-
veira et al., 2004). SIRP-1α may also help regulate mono-
1nuclear cell activation to self-antigens through its abil-
eity to bind the ligand CD47, whereas PIR-B may also
tregulate B cell receptor and FcRI function (Chen et al.,
p2002; Maeda et al., 1999). PIR-B-deficient mice mani-
lfest augmented B cell responses to BCR stimulation as
Mwell as defects in DC maturation (Ujike et al., 2002).
nIn examining neutrophil migration in mice lacking the
nmyeloid Src family kinases, we made the surprising ob-
aservation that deficiency of both Hck and Fgr resulted in
Aparadoxically augmented responses to CXCL1 (MIP-2)
wand CCL3 (MIP-1α). Dendritic cells from single deficient
tfgr−/− also manifested similar hyperresponsive pheno-
type to chemokines CCL19 and CCL21. Through bio-
pchemical and genetic means, we have demonstrated
tthat at least part of this negative regulation by Hck and
pFgr is mediated via the inhibitory receptor PIR-B. These
ufindings challenge the traditional role for Src family ki-
anases in GPCR signaling pathways and provide a func-
wtional role for the inhibitory receptor PIR-B.
s
hResults
F
chck−/−fgr−/− Neutrophils Have Enhanced Signaling
fResponses to Chemokine Stimulation r
Stimulation of leukocytes with chemokines results in an d
immediate production of IP3, which causes release of a
intracellular Ca2+ from endoplasmic reticulum stores.
By using a fluo-3 flow cytometric assay, we found that s
neutrophils from double mutant hck−/−fgr−/− mice dis- b
played significantly higher peak Ca2+ flux after stimula- c
tion with a number of chemokines, including murine s
MIP-1α, MIP-2, KC, and a human IL-8 (Figure S1 avail- n
able with this article online). (Throughout this manu- t
script, we will use the old nomenclature for MIP-1α m
(CCL3) and MIP-2 (CXCL1) because murine CCL3 and t
CXCL1 refer to several different molecular species be- s
sides just MIP-1α or MIP-2 [Thorpe, 2003].) To more d
thoroughly investigate this, we focused on responses n
to MIP-1α (a CCR1 ligand) and MIP-2 (a CXCR2 ligand). r
Across a wide dose-response range, double mutant t
hck−/−fgr−/− neutrophils demonstrated significantly in- s
creased peak Ca2+ flux responses compared to either f
wt or single mutant hck−/− or fgr−/− cells after stimula- m
tion by either MIP-1α or MIP-2 (Figures 1A and 1E). Tri- o
ple mutant hck−/−fgr−/−lyn−/− neutrophils displayed the
equivalent hyperresponsive phenotype to MIP-1α and f
MIP-2 as the double mutant hck−/−fgr−/− in the Ca2+ flux R
assay as well as in all the other assays described below T
s(data not shown). In contrast, single mutant lyn−/− neu-rophils showed a modest but reproducible decrease in
hemokine signaling responses in the Ca2 flux assay as
ell as most other assays described below (data not
hown). Because the most obvious chemokine signal-
ng changes were observed in hck−/−fgr−/− neutrophils,
e focused on these animals as well as cells derived
rom single mutant hck−/− and fgr−/− mice.
To examine whether Hck and Fgr are involved in
rk1/Erk2 activation after MIP-1α or MIP-2 stimulation,
e used phosphospecific anti-Erk1/Erk2 mAbs to ex-
mine the activation of these enzymes in wt versus mu-
ant cells. Double mutant hck−/−fgr−/− neutrophils dem-
nstrated consistently higher Erk1/Erk2 activation at
irtually all doses of MIP-1α and MIP-2 tested (Figures
B and 1F), whereas single mutant cells responded
quivalently to wt cells. Although the extent of activa-
ion of Erk1/Erk2 was higher in the hck−/−fgr−/− neutro-
hils, the rate of activation was approximately equiva-
ent to wt cells (Figure S2). Generation of phospho-p38
AP kinases was weakly increased in all genotypes of
eutrophils in response to both MIP-1α and MIP-2, but
o significant differences were observed between wt
nd any of the Src family mutants (data not shown).
ctivation of JNK was not observed after stimulation
ith either chemokine in any of the murine neutrophils
ested.
Stimulation of neutrophils with chemokines results in
olymerization of F-actin as a consequence of activa-
ion of Rho-family GTPases. We determined F-actin
olymerization after MIP-1α or MIP-2 stimulation by
sing a rhodamine-phalloidin binding/flow cytometry
ssay. In quiescent neutrophils, the amount of F-actin
as equivalent between wt and mutant cells. After
timulation with either MIP-1α or MIP-2 double mutant
ck−/−fgr−/−, neutrophils showed significantly increased
-actin polymerization compared to wt or single mutant
ells (Figures 1C and 1G). Although the extent of F-actin
ormation was higher in hck−/−fgr−/− neutrophils, the
ates of both F-actin polymerization and subsequent
epolymerization were approximately equivalent amongst
ll cell types.
The common response of leukocytes to chemokine
timulation is chemotaxis. Chemotaxis was determined
y assessing migration of cells through uncoated poly-
arbonate filters into chemokine containing wells. As
hown in Figures 1D and 1H, double mutant hck−/−fgr−/−
eutrophils manifested increased chemotactic responses
o both MIP-1α and MIP-2 stimulation, whereas single
utant cells responded equivalently to wt cells. Impor-
antly, all genotypes of cells showed classical bell-
haped dose response curves in this assay, with
ecreasing chemotaxis seen at higher doses. This phe-
omenon has been ascribed to rapid desensitization
esponses due to receptor phosphorylation/internaliza-
ion at higher chemokine doses (Kraft et al., 2001). In
ummary, these data indicate that deficiency of the Src
amily kinases Hck and Fgr in neutrophils results in aug-
ented signaling and functional responses to agonists
f both CXCR2 and CCR1.
gr−/− and hck−/−fgr−/− DCs Have Enhanced Signaling
esponses to CCL19 and CCL21
o determine if the chemokine signaling alterations ob-
erved in hck−/−fgr−/− neutrophils were also present in
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237Figure 1. hck−/−fgr−/− Mutant Neutrophils Have Enhanced Responses to MIP-1α and MIP-2
(A and E) Neutrophils from wt, hck−/−, fgr−/−, and hck−/−fgr−/− mice were labeled with fluo-3 then stimulated with the indicated doses of MIP-
1α or MIP-2, and peak levels of intracellular Ca2+ flux were determined by flow cytometry. Each bar shows the peak fluorescence level of
intracellular Ca2+ minus the baseline fluorescence. A complete Ca2+ flux tracing for these stimulations is shown in Figure S1.
(B and F) Neutrophils from the indicated genotypes of mice were stimulated with MIP-1α (120 s) or MIP-2 (150 s), after which cells were lysed
and phospho-Erk1/Erk2 was determined by immunoblotting. Each immunoblot was probed with anti-phospho Erk1/Erk2 (examples are shown
in the insets) and total Erk1/Erk2 to control for loading (not shown in this Figure, see Figure S2 for examples), and the amount of phospho-
Erk1/Erk2 was determined by densitometric tracing.
(C and G) Neutrophils from the indicated genotypes of mice were stimulated with 25 ng/ml or 10 ngl/ml of MIP-1α or MIP-2, respectively, and
assayed for polymerization of intracellular F-actin at the indicated time points by phalloidin staining. All data have the baseline values of
phalloidin staining (i.e., unstimulated cells) subtracted, hence, the values start at 0 MFI.
(D and H). Neutrophils from the indicated genotypes of mice were studied for chemotactic responses to MIP-1α or MIP-2 by using 96-well
Boyden chambers. The concentration of the chemokine in the lower wells is indicated.
For all data, statistical analysis is shown as ***p < .001, **p < .01, and *p < .05 compared to wt cells as determined by Student’s t test. Data
are presented as the mean ± SD from three to four separate experiments.
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238Figure 2. fgr−/− and hck−/−fgr−/− DCs Have Increased Responses to CCL19 and CCL21
(A and D) Splenic DCs from wt, hck−/−, fgr−/−, or hck−/−fgr−/− mice were sorted into CD11b+CD11c+ populations (97% purity) then stimulated
with CCL19 or CCL21 (25 ng/ml) for 2 min, and Erk1/Erk2 phosphorylation was determined by immunoblotting. Insets show phospho-Erk1/
Erk2 blottings, which were quantitated and plotted.
(B and E) Splenic DCs from the indicated genotypes of mice were stimulated with CCL19 or CCL21 (25 ng/ml) then assayed for F-actin
polymerization. Data shown are from a single time point (15 s) at the peak response of F-actin polymerization. The baseline values of phalloidin
staining in unstimulated cells were subtracted from each determination. Baseline phalloidin staining between wt and mutant DCs was not
significantly different.
(C and F) Splenic DCs from the indicated genotypes of mice were assessed for chemotaxis to CCL19 and CCL21 by using 24-well tissue
culture transwells. Cells were allowed to migrate in response to the two indicated doses of chemokine for 2 hr and the percentage of total
input CD11c+ cells that had crossed the transwell filter was determined by flow cytometry. Data were normalized to fold increase over control.
For all data, statistical analysis is shown as ***p < .001 and **p < .01 compared to wt cells as determined by Student’s t test. Data are
presented as the mean ± SD from three to five separate experiments.other myeloid cell types, we examined the response of
Dsplenic-derived DCs to stimulation by CCL19 and CCL21.
For these experiments, splenic DCs were obtained from t
lmice injected with a tumor cell line producing murine
GM-CSF, matured by culture with LPS, then stimulated L
kwith CCL19 or CCL21. There were no reproducible dif-
ferences in the yield of splenic DCs from wt versus fgr−/− 2
for hck−/−fgr−/− mice, nor where any differences in stain-
ing for various DC markers (CD11c, MHC II, and CD80/ m
t86) either prior to or after LPS-induced maturation ob-
served. Moreover, we have observed no differences in C
tAg-presenting capacity of DCs from hck−/−fgr−/− mice
(C.-L.C., unpublished data), thus we do not believe that t
Athe deficiency of these kinases affects development or
maturation of DCs. tWe assessed three signaling/functional responses of
Cs to CCL19 or CCL21 stimulation: Erk1/Erk2 activa-
ion, actin polymerization, and chemotaxis. Significant
evels of intracellular Ca2+ flux were not observed with
PS-matured DCs after stimulation with these chemo-
ines, as has been previously reported (Scandella et al.,
004). As shown in Figures 2A and 2D, DCs derived
rom both fgr−/− single mutant and hck−/−fgr−/− double
utant mice displayed significantly increased activa-
ion of Erk 2 after stimulation with either CCL19 or
CL21. Notably in DCs, we observed only Erk 2 activa-
ion after chemokine stimulation, which contrasts with
he pattern of Erk activation observed in neutrophils.
ctin polymerization responses of DCs were also de-
ectable after CCL19 or CCL21 stimulation, though the
Regulation of Chemokine Signaling by Src Kinases
239Figure 3. CD45−/− Neutrophils Are Hyperres-
ponsive to Chemokine Stimulation
All assays shown were performed as de-
scribed in Figure 1. A single dose, 25 ng/ml
for MIP-1α or 10 ng/ml for MIP-2, was tested
in each assay. (B) shows an individual ex-
periment, but the averaged data are shown
as numerical values below each lane.
(A) Peak Ca2+ flux responses in wt versus
CD45−/− neutrophils.
(B) Activation of Erk1/Erk2 in wt versus
CD45−/− neutrophils.
(C) F-actin polymerization in wt versus
CD45−/− neutrophils. The baseline values of
phalloidin staining in unstimulated cells,
which were the same in wt and CD45−/−
cells, were subtracted from each determi-
nation.
(D) Boyden chamber chemotaxis of wt ver-
sus CD45−/− neutrophils. Note that for this
figure that data are plotted relative to con-
trol, unstimulated cells for each genotype.
The deficiency of CD45 significantly lowered
the level of acid phosphatase in resting neutrophils, which is the enzymatic assay used to count cells.
For all data, statistical analysis is shown as ***p < .001, **p < .01, and *p < .05 compared to wt cells as determined by Studen’ts t test. Data
are presented as the mean ± SD from three separate experiments.responses tended to be less robust than in neutrophils.
Nevertheless, by using the phalloidin binding assay,
we reproducibly observed enhanced polymerization of
F-actin at the 15 s peak time point in DCs derived from
fgr−/− single mutant or hck−/−fgr−/− double mutant ani-
mals after both CCL19 and CCL21 stimulation (Figures
2B and 2E). Similar to the Erk activation and actin poly-
merization assays, both single mutant fgr−/− and double
mutant hck−/−fgr−/− DCs manifested significantly en-
hanced chemotactic responses to CCL19 and CCL21
stimulation compared to wt cells (Figures 2C and 2F) at
both doses of chemokine tested. Overall, these ob-
servations demonstrate that DCs lacking the single
Src family kinase Fgr demonstrated significantly aug-
mented responses to CCR7 ligands. This contrasts
from neutrophils, where exaggerated chemokine stimu-
lation was only observed in double hck−/−fgr−/− mutant
cells, indicating that Hck is unable to compensate for
the inhibitory function of Fgr in DCs. This difference
was not due to relative lack of Hck expression in DCs,
as like neutrophils, DCs express easily detectable
levels of Hck (Figure S7A)
CD45-Deficient Neutrophils Have Enhanced
Chemokine Responses
To distinguish whether the tyrosine kinase activity of
Hck and Fgr or just the presence of Hck/Fgr protein
was required for the hyperresponsiveness to chemo-
kine stimulation, we examined cells from CD45 knock-
out mice. The tyrosine phosphatase CD45 regulates Src
family kinase activity by dephosphorylating a regulatory
tyrosine at the C terminus of the kinases, allowing them
to unfold and become enzymatically activated (Hermis-
ton et al., 2003). Therefore, if the tyrosine kinase activity
(versus a nonkinase adaptor function) of Hck and/or
Fgr is required for their inhibitory function, we would
predict that neutrophils from CD45−/− mice should also
manifest augmented responses to MIP-1α and MIP-2.
As shown in Figures 3A–3D, CD45−/− neutrophils hadincreased peak Ca2+ flux responses, Erk1/Erk2 activa-
tion, actin polymerization, and chemotactic responses
in response to MIP-1α and MIP-2 stimulation compared
to wt cells. The degree of hyperresponsiveness of the
CD45−/− neutrophils was similar to that observed in
hck−/−fgr−/− cells. Together, these data suggest that the
majority of the inhibitory function of these Src family
kinases is dependent upon their kinase activity.
hck−/−fgr−/− Neutrophils and DCs Express Normal
Levels of Chemokine Receptors that Display
Normal Desensitization to Repetitive Stimulation
To address possible mechanisms causing the hyperre-
sponsive phenotype of hck−/−fgr−/− cells to chemokine
stimulation we examined receptor expression and de-
sensitization characteristics. For neutrophils, we di-
rectly measured the CCR1 and CXCR2 expression and
affinity by using 125I-labeled MIP-1α and MIP-2 in com-
petition binding experiments. For DCs, we measured
CCR7 by using a CCL19/Fc fusion protein as a staining
reagent. In both cases, we found no difference between
wt and hck−/−fgr−/− cells in receptor expression (Figure
S3 and Supplemental Results).
The exaggerated responses of hck−/−fgr−/− neutro-
phils may be a result of impaired receptor recycling and
reduced desensitization responses. To address this is-
sue, we examined the desensitization of wt versus mu-
tant neutrophils in two different assays: Ca2+ mobiliza-
tion and chemotaxis. Isolated neutrophils were first
exposed to low doses of MIP-1α or MIP-2, washed,
then restimulated, and the effects on secondary re-
sponses were observed. Both wt and hck−/−fgr−/− neu-
trophils showed a significantly blunted response to re-
stimulation (Figure S4 and Supplemental Results). We
conclude that the deficiency of Hck and Fgr do not alter
normal homologous desensitization responses of CCR1
or CXCR2 to repeated stimulation.
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240Figure 4. pir-b−/− Neutrophils and DCs Are
Hyperresponsive to Chemokine Stimulation
All assays were performed as described in
Figures 1 and 2. MIP-1α and MIP-2 were
used at 25 ng/ml and 10 ng/ml, respectively,
whereas CCL19 and CCL21 were used at 25
ng/ml. Erk activation shows a single experi-
ment, but the averaged data are shown as
numerical values below each lane.
(A) Peak Ca2+ flux responses in wt versus
pir-b−/− neutrophils.
(B and E) Activation of Erk1/Erk2 in wt versus
pir-b−/− neutrophils and DCs.
(C and F) Peak F-actin polymerization in wt
versus pir-b−/− neutrophils and DCs. The
baseline values of phalloidin staining in un-
stimulated cells, which were the same in wt
and pir-b−/− neutrophils and DCs, were
subtracted from each determination.
(D and G) Chemotaxis in wt versus pir-b−/−
neutrophils and DCs. Both the neutrophils
and DCs from the pir-b−/− mice tended to
show lower spontaneous migration of un-
stimulated cells, compared to wt, consistent
with the hyperadhesive phenotype of these
cells as we have previously reported (Pereira
et al., 2004). Therefore, these data are plot-
ted relative to the control, unstimulated cells.
However, when stimulated the pir-b−/− cells
displayed a significantly higher fold increase
in migration, as shown.
For all data, statistical analysis is shown as
**p < .01 and *p < .05 compared to wt cells
as determined by Student’s t test.
Data are presented as the mean ± SD from
three to four separate experiments.Defective PIR-B Inhibitory Function f
in hck−/−fgr−/− Neutrophils n
We used a mAb crosslinking approach to investigate E
the possibility that defective inhibitory receptor signal- r
ing may contribute to the hyperresponsive phenotype T
of hck−/−fgr−/− neutrophils. First, we found that hck−/− p
fgr−/− neutrophils expressed normal levels of the inhibi- f
tory receptors SIRP-1α, PIR-B, and FcγRIIB (Figure S5). a
In wt neutrophils, when these receptors were cross- t
linked prior to chemokine stimulation, the cells demon- t
strated an augmented Ca2+ mobilization response. This d
did not occur in hck−/−fgr−/− cells (Figures S6A and S6B n
and Supplemental Results). Correlated with these re- m
sults is the fact that PIR-B was constitutively phos- a
phorylated in neutrophils, whereas SIRP-1α remained d
unphosphorylated in both resting and chemokine-stim- a
ulated cells (Figure S6C). We also ruled out contribu- t
tions from FcγRIIB by examining neutrophils from
fcgRIIB−/− mice, which responded normally. We con-
Pclude that of the three inhibitory receptors on murine
Sneutrophils, only PIR-B contributes to the regulation of
Tchemokine signaling, and this function was absent in
ohck−/−fgr−/− cells.
r
nDeficiency of PIR-B Results in Increased
nResponses to Chemokine Stimulation
wTo more convincingly implicate PIR-B in negative regu-lation of chemokine signaling, we studied cells derivedrom pir-b−/− mice. Similar to hck−/−fgr−/− cells, pir-b−/−
eutrophils displayed increased peak Ca2+ flux, Erk1/
rk2 activation, actin polymerization, and chemotactic
esponses to both MIP-1α and MIP-2 (Figures 4A–4D).
he degree of hyperresponsiveness of pir-b−/− neutro-
hils approximated the phenotype seen in hck−/−
gr−/− cells. Similarly, splenic DCs from pir-b−/− mice
lso manifested increased Erk1/Erk2, actin polymeriza-
ion, and chemotaxis to CCL19 and CCL21 compared
o wt cells (Figures 4E–4G). However, in this case, the
egree of hyperresponsiveness of the pir-b−/− DCs was
ot as dramatic as observed in hck−/−fgr−/− cells, which
ay reflect the fact that deficiency of PIR-B is known to
ffect DC maturation as well (Ujike et al., 2002). These
ata demonstrate that deficiency of PIR-B results in ex-
ggerated chemokine signaling responses in both neu-
rophils and DCs.
IR-B Phosphorylation and Association with SHP-1/
HP-2 Is Lost in hck−/−fgr−/− Cells
he observation that deficiency of either Hck and Fgr
r PIR-B results in exaggerated chemokine signaling
esponses would suggest that one or both of these ki-
ases contributes to the phosphorylation of PIR-B in
eutrophils and DCs. Indeed, phosphorylation of PIR-B
as dramatically reduced in resting and chemokine-stimulated neutrophils from hck−/−fgr−/− mice (Figure
Regulation of Chemokine Signaling by Src Kinases
241Figure 5. Tyrosine Phosphorylation of PIR-B
and Association of PIR-B with SHP-1/SHP-2
Is Reduced in hck−/−fgr−/− Neutrophils and
DCs
(A) Neutrophils (40 × 106) from wt or hck−/−
fgr−/− mice were left resting (Ctrl) or stim-
ulated with MIP-1α or MIP-2 (100 ng/ml) for
2 or 2.5 min, respectively, and lysed. PIR-B
was immunopreciptated with polyclonal anti-
sera and subjected to immunoblotting with
antiphosphotyrosine. The right panel shows
the level of PIR-B tyrosine phosphorylation
in resting (Ctrl) wt, hck−/−, and fgr−/− cells.
The lower panels show the same blots
stripped and reprobed with anti-PIR-B to
confirm equal loading.
(B) DCs (20 × 106) from wt or hck−/−fgr−/−
mice were left resting (Ctrl) or stimulated
with CCL19 (100 ng/ml) for 2 min and lysed.
PIR-B was immunopreciptated with poly-
clonal antisera and subjected to immu-
noblotting with antiphosphotyrosine. The
right panel shows the level of PIR-B tyrosine
phosphorylation in resting (Ctrl) hck−/− and
fgr−/− cells. The lower panels show the same
blots stripped and reprobed with anti-PIR-B
to confirm equal loading.
(C) Neutrophils (60 × 106) from wt or hck−/−
fgr−/− mice were left resting (Ctrl) or stim-
ulated with MIP-1α or MIP-2 (100 ng/ml) for
2 or 2.5 min, lysed, immunoprecipitated with
either polyclonal anti-SHP-1 (upper panels)
or SHP-2 (lower panels) then subjected to
immunoblotting with anti-PIR-B. The lower
panel in each set shows the above filters af-
ter stripping and reprobing with anti-SHP-1
or SHP-2 to confirm equal loading.
(D) DCs (20 × 106) from wt mice were left
resting (Ctrl) or stimulated with CCL19 or
CCL21 (100 ng/ml) for 2 min and lysed. Ly-
sates were immunoprecipitated with poly-
clonal anti-SHP-1 (upper panels) then subjected to immunoblotting with anti-PIR-B. The lower panels confirm equal precipitation of SHP-1 in
each lane.
(E) Neutrophils (40 × 106) from wt mice were left resting (Ctrl) or stimulated with MIP-1α or MIP-2 (at 100 ng/ml) for the indicated time points
then lysed. PIR-B was immunoprecipitated and immunoblotted for phosphotyrosine.
Data are representative of at least three independent experiments.5A). Neutrophils from single mutant fgr−/− mice also dis-
played a reduced level of PIR-B phosphorylation com-
pared to hck−/− or wt cells. Interestingly, these exper-
iments consistently demonstrated a drop in PIR-B
phosphorylation after MIP-1α or MIP-2 stimulation (Fig-
ures 5A, 5E, 6E, and S6C). In neutrophils, the kinetics of
PIR-B dephosphorylation were transient; the maximum
decrease in PIR-B phosphorylation correlated with the
time points of peak Erk1/Erk2 activation (Figure 5E). In
DCs, PIR-B phosphorylation also dropped after chemo-
kine stimulation but was consistently very low in both
hck−/−fgr−/− and single mutant fgr−/− cells (Figure 5B).
Impaired tyrosine phosphorylation of PIR-B would be
expected to result in reduced association of the recep-
tor with the tyrosine phosphatases SHP-1 and SHP-2.
By using a coimmunoprecipitation assay, we found that
PIR-B association with both SHP-1 and SHP-2 was un-
detectable in hck−/−fgr−/− neutrophils (Figure 5C). Asso-
ciation of these phosphatases with PIR-B in wt cells
also decreased after chemokine stimulation of either
neutrophils or DCs (Figures 5C and 5D). These data de-
monstrate that deficiency of Fgr reduces, whereas loss
of both Hck and Fgr together completely abrogates,phosphorylation of PIR-B. Reduced phosphorylation of
the receptor results in impaired recruitment of SHP-1
or SHP-2, which may contribute to the hyperresponsive
chemokine signaling seen in both hck−/−fgr−/− and
pir-b−/− cells. In wt cells, chemokine stimulation also
results in a transient decrease of PIR-B tyrosine phos-
phorylation with reduced recruitment of SHP-1 and
SHP-2.
The unusual dephosphorylation of PIR-B after chem-
okine stimulation may be secondary to either increased
phosphatase activity or reduced tyrosine kinase activ-
ity. However, we found no changes in either Hck/Fgr
tyrosine kinase activity, association with PIR-B, or
association with Gαi after chemokine stimulation (Fig-
ure S7).
Deficiency of the SHP-1 Phosphatase Results
in Hyperresponsive Chemokine Signaling
If the reduction in SHP-1/SHP-2 recruitment to PIR-B
contributes to increased chemokine signaling, then
cells lacking these phosphatases should also show the
same phenotype. We analyzed cells derived from
motheaten viable (mev/mev) mice, which have a point
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All assays were performed as described in Figures 1 and 2. In (A)–(C), MIP-1α and MIP-2 were used at 25 ng/ml and 10 ng/ml, respectively,
whereas CCL19 was used at 25 ng/ml. Erk activation shows a single experiment, but the averaged data are shown as numerical values below
each lane. Experiments using neutrophils and DCs are plotted on the same graphs for simplicity.
(A) Peak F-actin polymerization in wt versus mev/mev neutrophils and DCs. Data shown have the baseline phalloidin staining of unstimulated
cells subtracted. There was a significant difference between wt and mev/mev cells in F-actin content of resting cells—mev/mev cells had a
significantly higher phalloidin staining in resting cells. As shown, they also manifested a larger change in F-actin polymerization after stimu-
lation.
(B) Chemotaxis in wt versus mev/mev neutrophils and DCs. Chemotaxis data are normalized to migration of unstimulated cells. The mev/mev
neutrophils and DCs tended to show a significantly lower spontaneous migration of unstimulated cells than wt, consistent with the hyperadhe-
sive phenotype of these cells (Roach et al., 1998). However, when stimulated they displayed a significantly higher fold increase in migration,
as shown.
(C) Activation of Erk1/Erk2 in wt versus mev/mev DCs.
(D) Neutrophils (30 × 106) from wt or mev/mev mice were left resting (Ctrl) or stimulated with MIP-1α or MIP-2 (100 ng/ml) for 2 or 2.5 min,
respectively, and membrane or cytosolic preparations were prepared and immunoblotted with anti SHP-1. Also shown is a whole-cell lysate
sample from an equivalent number of neutrophils that was diluted 1/20 and run on the same blot as the membrane fractions to provide an
estimate of the total cellular pool of SHP-1 that is membrane localized. The panel below shows the cytosolic fractions that were prepared
from the same preparations.
(E) Neutrophils (40 × 106) from wt, hck−/−fgr−/−, or mev/mev mice were stimulated with MIP-1α or MIP-2 (100 ng/ml), and PIR-B phosphorylation
was determined as described in Figure 5. The lower panel shows the same blot stripped and reprobed with anti-PIR-B to confirm equal
loading.
For all data, statistical analysis is shown as **p < .01 compared to wt cells as determined by Student’s t test. All data shown are averaged
from three to four independent experiments ± SD.mutation within the shp-1 gene that severely reduces t
sexpression of SHP-1 protein (Tsui et al., 1993). Similar
to previous studies in myeloid precursor cells, macro- d
Sphages, B-, and T lymphocytes (Kim et al., 1999), we
found that neutrophils and DCs from mev/mev mice t
amanifested increased actin polymerization, chemotaxis,
and Erk1/2 activation when stimulated with MIP-1α, h
OMIP-2, or, in the case of the DCs, CCL19 (Figures 6A–6C).
The differential association of SHP-1/SHP-2 with w
PIR-B as a function of changes in receptor phosphory-
lation after chemokine stimulation would predict that ohe levels of these phosphatases in the membrane ver-
us cytosolic fractions of the cell should change. In-
eed, we were able to readily see the movement of
HP-1 and SHP-2 from the membrane fraction of neu-
rophils after MIP-1α or MIP-2 stimulation (Figures 6D
nd S7D). As predicted, membrane preparations from
ck−/−fgr−/− neutrophils had very little SHP-1/SHP-2.
verall, the total cellular fraction SHP-1 associated
ith membranes was estimated to be 1%–3%.
The biochemical studies raise the obvious question
f what phosphatase is responsible for transiently de-
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To address whether SHP-1 itself may be responsible,
we examined PIR-B phosphorylation in mev/mev neu-
trophils. As shown in Figure 6E, PIR-B phosphorylation
in resting mev/mev cells was significantly higher than in
resting wt cells, but like wt cells, MIP-1α or MIP-2 stimu-
lation resulted in a transient decrease in PIR-B phosphor-
ylation. Therefore, these data indicate that other phos-
phatases, potentially SHP-2, are responsible at least in
part for the transient dephosphorylation of PIR-B that
accompanies activation of chemokine signaling.
hck−/−fgr−/−, CD45−/−, and pir-b−/− Neutrophils
and DCs Have Enhanced Migration In Vivo
The above experiments would predict that leukocytes
from hck−/−fgr−/−, pir-b−/−, or CD45−/− mice should show
altered migration in various in vivo models. To examine
neutrophil migration, we used the thioglycollate-induced
sterile peritonitis model. Similar to the results seen in
in vitro chemotaxis experiments, hck−/−fgr−/− mice
mounted a significantly higher amount of peritoneal in-
flammation at the peak of the response (6 hr) than did
wt mice (Figure 7A). Similarly, the peak neutrophil mi-
gratory response of CD45−/− and pir-b−/− mice was also
elevated, whereas single mutant hck−/− or fgr−/− animals
were equivalent to wt (Figure 7B). These results confirm
that disruption of the Hck/Fgr-PIR-B signaling pathway
produces increased acute inflammation in a peritonitis
model.
To assess DC migration, we tracked the movement of
CFSE-labeled cells from the skin into regional draining
lymph nodes. After injection of wt DCs, 2%–4% of in-
guinal lymph node DCs were CFSE-labeled. hck−/−
fgr−/−, fgr−/−, and pir-b−/− DCs showed significantly
higher migration into the regional lymph nodes com-
pared to wt (Figures 7C and 7D). We conclude that the
alteration in CCR7 signaling caused by loss of Fgr or
PIR-B results in enhanced migration of these cells from
peripheral sites to draining lymph nodes.
Discussion
A number of prior studies have defined a positive func-
tional role for Src family kinases in GPCR signaling.
These studies include signaling from chemoattractant
receptors in neutrophils, including the fMLP, comple-
ment receptor, C5a, and platelet-activating receptors
(Berton, 1999; Lo et al., 2003; Mocsai et al., 1999, 2000)
as well as chemokines such as CXCL8 (IL-8) and eo-
taxin (Barlic et al., 2000; El-Shazly et al., 1999). How-
ever, in the majority of these cases, the data are based
on use of tyrosine kinase inhibitors or studies in estab-
lished cell lines. By using primary neutrophils from
hck−/−fgr−/− mutant mice, we find that these kinases
contribute to a negative regulatory loop controlling
CCR1 and CXCR2 signaling, whereas in primary DCs,
Fgr alone functions as a negative regulator of CCR7.
Deficiency of these kinases results in augmented Erk
activation, actin polymerization, and chemotactic re-
sponses in neutrophils and DCs, both in vitro and in vivo,
whereas kinase mutant neutrophils also manifested in-
creased Ca2+ mobilization after CCR1 or CXCR2 stimu-
lation. The mechanism of this inhibition is mediated, atleast in part, through the inhibitory receptor PIR-B in
both cell types, based primarily on the observation that
deficiency of PIR-B produces the same phenotype as
loss of Hck/Fgr activity and the fact that these kinases
contribute to the phosphorylation of PIR-B in these cell
types. Overall, these observations describe what may
be a new functional role for these tyrosine kinases as
well as the PIR-B inhibitory receptor. To our knowledge,
there are few examples of an ITIM-containing receptor
controlling signaling outcomes from GPCRs.
The mechanism by which the Hck/Fgr-PIR-B path-
way regulates chemokine signaling is significantly dif-
ferent than in other models of ITIM receptors regulating
cellular activation. For most inhibitory receptors, cellu-
lar stimulation (either through antigen receptors, Fc re-
ceptors, or via cytokines) results in transiently in-
creased phosphorylation of the receptor, which in turn
results in recruitment of SHP-1/SHP-2 and subsequent
downmodulation of signaling (DeFranco et al., 1998;
Harder et al., 2001). In both B lymphocytes and macro-
phages, PIR-B has been found to be constitutively
phosphorylated and associated with SHP-1—further
cellular activation does not change the level of PIR-B
phosphorylation (Ho et al., 1999). We find similar results
in primary neutrophils and DCs, with the additional ob-
servation that chemokine stimulation of either cell type
results in transiently diminished phosphorylation of
PIR-B and reduced association of the receptor with
SHP-1/SHP-2. These observations lead to a more un-
usual model of regulation by this inhibitory receptor,
which is summarized in Figure 7E. Through tonic phos-
phorylation by Src family kinases (primarily Fgr and to
a lesser extent Hck), PIR-B is maintained in a constitu-
tively phosphorylated state, thus supplying a con-
tinuous level of inhibitory function (probably on multiple
pathways). After engagement of the chemokine recep-
tor by ligand, the phosphorylation level of PIR-B tran-
siently drops, resulting in reduced association with
SHP-1 and SHP-2. The mechanism of this decrease in
PIR-B phosphorylation is not clear but likely does not
involve changes in Hck/Fgr kinase activity or changes
in Hck/Fgr association with Gαi, but could be due to
changes in kinase localization in the membrane. Be-
cause chemokine-induced PIR-B dephosphorylation
also occurs in mev/mev cells (Figure 6E), SHP-1 itself is
not the phosphatase acting on PIR-B. However, PIR-B
dephosphorylation is achieved after chemokine stimu-
lation, and the result is a transiently reduced membrane
association of SHP-1 and SHP-2 (Figures 6D and S7D),
which in turn would allow maximization of downstream
signaling events. Hence, in this model, PIR-B acts a
tonic brake to signaling, which is relaxed after ligand
stimulation.
Given the hypermigratory phenotype of pir-b−/− neu-
trophils, it would be predicted that these mice should
develop more severe inflammatory reactions in various
disease models. Indeed, pir-b−/− mice do show exag-
gerated responses to the development of graph versus
host disease in allogenic transplantation models (Naka-
mura et al., 2004). It is interesting to speculate that part
of the pathogenesis of this response may be due to
increased DC migratory responses in pir-b−/− mice.
PIR-B is the ortholog of the human leukocyte immuno-
globulin-like receptors (LILRs); modulation of the ex-
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and DCs Show Enhanced Migration In Vivo
(A) Wt and hck−/−fgr−/− mice were injected
i.p. with 3% thioglycollate, and the number
of neutrophils in peritoneal lavage fluid at the
indicated time points was determined by
flow cytometry (double staining for CD45.2/
Gr1). Data shown are based on five mice per
time point and is representative of two inde-
pendent experiments.
(B) Peritoneal migration of neutrophils in wt,
hck−/−, fgr−/−, hck−/−fgr−/−, CD45−/−, and
pir-b−/− mice (four animals per group) 6 hr
after 3% thioglycollate injection determined
as in (A).
(C) CFSE-labeled DCs (4 × 106) from wt,
hck−/−fgr−/−, or pir-b−/− mice were injected
into the foot pad of wt recipient mice (four
animals per group), and the percentage of
injected cells that were recovered 48 hr later
from the draining inguinal lymph node was
determined by flow cytometry (double stain-
ing for CD11c+/CFSE labeled cells). Data
shown are from an individual experiment and
is representative of four independent experi-
ments.
(D) Migration of CFSE-labeled DCs from wt,
hck−/− or fgr−/−, or mice as performed in (C).
For all data, statistical analysis is shown as
**p < .01 and *p < .05 compared to wt cells
as determined by Student’s t test. Data are
presented as the mean ± SD.
(E) Model of the participation of Src family
kinases Hck and Fgr plus the inhibitory re-
ceptor PIR-B in chemokine signaling. The
left panel depicts resting cells with higher
levels of phosphorylation of PIR-B (as main-
tained primarily by Fgr and, to a lesser ex-
tent, Hck) and associated SHP-1 (or SHP-2).
The constitutive association of the phospha-
tase with PIR-B restrains signaling from the
chemokine GPCR. The right panel depicts li-
gand stimulated cells with lower levels of
PIR-B phosphorylation, which results in less
SHP-1/SHP-2 association. The lower level of phosphatases at the membrane allows maximization of the chemokine GPCR signal. The tyrosine
phosphatase that acts on PIR-B is unknown and is indicated as an “X.”pression levels of the inhibitory LILRs have been impli- o
scated in autoimmune arthritis (Dulphy et al., 2002).
The observation that the Src family kinases Fgr and, s
gto a lesser extent, Hck are the major enzymes that regu-
late PIR-B phosphorylation and chemokine signaling is i
2also unique. In both B lymphocytes and macrophages,
the primary Src family kinase that is thought to phos- l
ophorylate PIR-B is Lyn (Ho et al., 1999; Maeda et al.,
1999). Indeed, we have also found reduced tyrosine a
bphosphorylation of PIR-B in neutrophils and DCs from
lyn−/− mice (data not shown). However, the extent of u
sreduction of PIR-B phosphorylation in lyn−/− cells was
not as great as in fgr−/− or especially hck−/−fgr−/− cells, T
tand more importantly, lyn−/− neutrophils displayed mod-
est reductions of chemokine signaling in most studies. n
JThus, although Lyn may contribute to the constitutive
phosphorylation of PIR-B in B cells and myeloid leuko- n
ucytes, it does not contribute to the negative regulation
of chemokine signaling. t
hAn obvious issue raised by these studies is the iden-
tification of potential substrates on which SHP-1 (and/ tr SHP-2) is operating to regulate chemokine re-
ponses. It is interesting to speculate that substrates
uch as JAKs and STATs may be involved. There is
rowing evidence that JAK/STAT signaling is involved
n leukocyte responses to chemokines (Mellado et al.,
001). In CD34+ hematopoietic progenitor cells, stimu-
ation of cells with CXCL12 (SDF-1α) leads to activation
f JAK2 and coupling of JAK2 to PI-3 kinase (Zhang et
l., 2001); treatment of cells with JAK inhibitors (AG490)
locks functional signaling responses to CXCL12 stim-
lation. Moreover, cell lines deficient in JAK2 fail to re-
pond to CXCL12 stimulation (Soriano et al., 2003).
reatment of primary lymphocytes with AG490 blocks
heir migration both in vitro and in vivo to CCR7 ago-
ists (CCL19/21) (Stein et al., 2003). The contribution of
AK/STAT tyrosine phosphorylation or activation has
ot been examined in primary neutrophils or DCs stim-
lated with the chemokines used in this study. Given
he role that tyrosine phosphatases such as SHP-1
ave in regulating JAK/STAT signaling, it is interesting
o speculate that decreased recruitment of SHP-1 to
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aggerated activation of either JAK kinases or hyper-
phosphorylation of STATs, which in turn could lead to
the increased signaling responses.
The observations reported here demonstrate a po-
tentially unique function for both Src family kinases and
the inhibitory receptor PIR-B. The ability of these ki-
nases and receptors to regulate ITAM-related signaling
is well understood, however, inhibitory control over
GPCR signaling has not been previously reported. A
major area of future work will involve understanding
how the same Src family kinases can be both positive
regulators of one type of GPCR pathway (such as sig-
naling degranulation via fMLP receptors) while nega-
tively regulating other GPCR pathways (such as CCR1
and CXCR2) in the very same cell type (neutrophils).
This question emphasizes the multifaceted nature of
these kinases.
Experimental Procedures
See Supplemental Experimental Procedures online for complete
methods.
Isolation of Bone Marrow Neutrophils and GM-CSF-Derived DCs
Murine bone marrow neutrophils were isolated essentially as de-
scribed (Pereira and Lowell, 2003). Splenic DCs were prepared from
mice injected subcutaneously with 5–10 × 106 GM-CSF-secreting
B16 melanoma cells as described (Mach et al., 2000).
Chemokine Functional Assays
Calcium flux assays were determined by using purified neutrophils
in a fluo-3 based flow cytometry assay. Neutrophils and DCs were
analyzed for chemokine-induced actin polymerization and chemo-
taxis as described (Mocsai et al., 2003).
Thioglycollate-Induced Peritonitis and DC Migration In Vivo
Mice were injected i.p. with 1 ml of 3% of thioglycollate broth
(UCSF Cell Culture Facility), and numbers of neutrophils in the peri-
toneal exudate was enumerated by Gr-1 staining/flow cytometry
(Mocsai et al., 2002). DC migration was performed by using CFSE-
labeled cells injected into the footpad followed by flow cytometry
of draining inguinal lymph nodes.
Subcellular Fractionation
After stimulation with indicated chemokines, neutrophils (3 × 107)
or DCs (2 × 107) were frozen in liquid nitrogen then fractionated
into membrane or cytosolic preparations by using low ionic
strength lysis. Samples of each fraction were used for SDS-PAGE/
Western blotting.
Immunoprecipitation, Western Blotting, and Kinase Assays
Immunoprecipitation methods were performed as previously de-
scribed (Lowell et al., 1996; Mocsai et al., 2003; Pereira and Lowell,
2003) by using polyclonal Abs goat anti-PIR-B (p91), rabbit anti-
SIRP-α (C-20), rabbit anti-SH-PTP1 (C-19), or rabbit anti-SH-PTP2
(c-18) antibody (all from Santa Cruz Biotechnology, Santa Cruz, CA)
followed by protein G agarose bead precipitation. Polyclonal anti-
phospho-p44/42 MAP kinase (Thr202/Tyr204) (Cell Signaling Technol-
ogy, Beverly, MA), rabbit anti-ERK1/ERK2 (Santa Cruz), anti-phospho-
tyrosine 4G10, anti-PIR-B, anti-SH-PTP1, and anti-SH-PTP2 were
used in Western blotting. Kinase assays were performed with poly-
clonal anti-Hck or anti-Fgr.
Supplemental Data
Supplemental Data including Supplemental Results, Supplemental
Experimental Procedures, Supplemental References, and sevenfigures are available with this article online at http://www.immunity.
com/cgi/content/full/22/2/235/DC1/.
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